Alimera Sciences (ALIM)
Alimera Sciences Revenues
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these ALIM related companies
ALIM News
Listen to $ALIM Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3mi4
about 16 days ago by earningscast
about 16 days ago by earningscast
Trading Radar for 05/11: Gordmans (GMAN), Dr. Reddys (RDY), Cache (CACH), Osiris Therapeutics (OSIR) Report
May 10, 5:52PM Street Insider
May 10, 5:52PM Street Insider
United Kingdom Grants ILUVIEN(R) Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema
May 07, 8:30AM GlobeNewswire
May 07, 8:30AM GlobeNewswire
$ALIM filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aSl
about 27 days ago by MarketBrief
about 27 days ago by MarketBrief
Alimera Sciences to Release First Quarter Fiscal Year 2012 Financial Results
Apr 26, 7:00AM GlobeNewswire
Apr 26, 7:00AM GlobeNewswire
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
Apr 24, 8:30AM GlobeNewswire
Apr 24, 8:30AM GlobeNewswire
pSivida (PSDV) Rips Again; Traders Eye Further European Approval for ILLUVIEN (ALIM)
Mar 27, 12:00PM Street Insider
Mar 27, 12:00PM Street Insider
Healthcare investors and capitalists actively looking for the next generation of market movers
Mar 23, 10:10AM Thomson Reuters ONE
Mar 23, 10:10AM Thomson Reuters ONE
$ALIM forms bullish "Flag" chart pattern. http://stks.co/31zx
about 65 days ago by RecogniaEvents
about 65 days ago by RecogniaEvents
Monday's High Tight Flags $BCRX $ALIM $KTCC $VVUS $OREX http://chart.ly/spytjaq
about 76 days ago by Woodshedder
about 76 days ago by Woodshedder
Listen to $ALIM Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2kCV
about 80 days ago by earningscast
about 80 days ago by earningscast
Douglas Godshall new board of director for $psdv and $alim is boosting $psdv.
about 82 days ago by ingramout
about 82 days ago by ingramout
@mb_willoughby Are you going to hold on to $ALIM for long run or day trade on patterns?
about 82 days ago by Mirac
about 82 days ago by Mirac
Alimera Sciences to Present at 32nd Annual Cowen & Company Health Care Conference
Mar 05, 10:15AM GlobeNewswire
Mar 05, 10:15AM GlobeNewswire
Alimera Sciences (ALIM) Moves up 130% on Week Due to Positive Results for Decentralized Procedure for ILUVIEN
Feb 28, 10:10AM Street Insider
Feb 28, 10:10AM Street Insider
Alimera Sciences (ALIM) Gets Positive Outcome for DCP of ILUVIEN in Europe
Feb 28, 6:45AM Street Insider
Feb 28, 6:45AM Street Insider
Alimera Sciences to Release Fourth Quarter and Fiscal Year 2011 Financial Results
Feb 21, 7:00AM GlobeNewswire
Feb 21, 7:00AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ALIM | 2.63 | +0.00 | +0.00% | 82.66M |
| ALGT | 64.04 | -0.21 | -0.33% | 1.222B |
| ALG | 30.55 | -0.06 | -0.20% | 362.93M |
| ALEX | 50.87 | -0.34 | -0.66% | 2.130B |
| ALE | 38.80 | +0.10 | +0.26% | 1.474B |
| ALD | 50.08 | -0.03 | -0.06% | |
| ALCO | 24.62 | -0.31 | -1.24% | 180.96M |
| ALC | 14.57 | -0.13 | -0.88% | 334.67M |
| AEG | 4.30 | -0.01 | -0.23% | 8.211B |
| AEE | 32.06 | +0.02 | +0.06% | 7.779B |
